Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeodomain-interacting protein kinase 2 (HIPK2) is a serine/threonine protein kinase that plays a crucial role in regulating gene expression, apoptosis, and cell cycle control. It is activated by genotoxic stress and functions as a tumor suppressor by promoting apoptosis, inhibiting angiogenesis, and preventing tumor invasion and metastasis. HIPK2 primarily modulates the activity of transcription factors, particularly p53, through phosphorylation. Altered expression or splicing variants of HIPK2 are implicated in various cancers, highlighting its complex role in tumorigenesis.
HIPK2 modulates the activity of transcription factors (e.g., p53) through phosphorylation, impacting gene expression related to apoptosis, cell cycle control, and DNA damage response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeodomain Interacting Protein Kinase 2.